We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Postoperative octreotide and metoclopramide were used in all patients for 3 days.
2
The combination of metoclopramide with other effective antiemetic agents may provide improved protection.
3
Swallow-induced motility was recorded manometrically before and after treatment with physostigmine or metoclopramide.
4
In no case was it necessary to discontinue metoclopramide because of adverse drug reactions.
5
These were diagnosed as migraines and were usually fixed by taking paracetamol or metoclopramide.
6
Our data do not support a directly proportional relationship between serum metoclopramide level and antiemetic protection.
7
Unlike metoclopramide, dazopride has no effect on dopamine receptors and therefore should not produce extrapyramidal side effects.
8
Objective: We conducted a randomized controlled trial to determine whether GONB was as effective as intravenous metoclopramide for migraine.
9
The pharmacology of metoclopramide is discussed with reference to the drug's known effects on vascular beds and platelet function.
10
Results: Significant differences in gastric electrical or contractile activities were not detected after metoclopramide treatment in dogs with GDV.
11
Conclusion: GONB with bupivacaine was not as efficacious as IV metoclopramide for the first-line treatment of migraine in the ED.
12
We hypothesized that HF patients respond to salt loading with increased production of renal dopamine and that metoclopramide antagonizes this response.
13
Ondansetron was superior to high-dose metoclopramide in controlling acute emesis and nausea, and there was a significant patient preference for ondansetron.
14
These encouraging results were rapidly followed by a series of pilot studies designed to extend the use of metoclopramide to other clinical situations.
15
The complete and major control rates observed show that ondansetron is as effective as or more effective than metoclopramide in controlling cisplatin-induced emesis.
16
The existence of a threshold serum metoclopramide level above which total protection from cisplatin-induced vomiting is more likely to occur has been proposed.